Danilo Geraldes

Danilo Geraldes, PhD, is a Medical Science Liaison in Rare Diseases at Biogen. With a robust background in Pharmaceutical Technology and Biotechnology from UNICAMP, Danilo has dedicated their career to enhancing clinical practices and patient outcomes. They began their pharmaceutical industry journey in 2021 as a Medical Information Analyst at Libbs Farmacêutica, later taking on a role at AstraZeneca where they contributed to the pre-launch strategy of a therapy for Transthyretin Amyloidosis. Danilo actively engages with healthcare professionals, facilitating scientific discussions and training while achieving strategic goals throughout their academic and professional endeavors.